ERC PoC grant for team Marc Vooijs: INGSIGHT: Inhibition of Notch /g-secretase in hypoxic tumors. The team will focus on two new lead compounds targeting Notch signaling in tumors using a newly developed dual-specificity small molecule inhibitor and an inhibitor targeted PSEN2. read more.
For more info: contact
December 2020: In collaboration with KU Leuven, Kim Kampen (Co-PI) received a grant to study "Serine/glycine synthesis addiction in acute lymphoblastic leukemia and resulting therapeutic opportunities".